Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Sernova Biotherapeutics Inc. (T.SVA) had Income from Continuous Operations of -2.02M for the most recently reported fiscal year, ending 2017-10-31.
| Income Statement Financials | |
-- |
|
-2.02M |
|
-- |
|
-- |
|
-- |
|
-2.02M |
|
-- |
|
-2.02M |
|
-2.02M |
|
-2.02M |
|
|
Income from Continuous Operations |
-2.02M |
-2.02M |
|
-2.02M |
|
-2.02M |
|
-1.99M |
|
158.24M |
|
158.24M |
|
-0.02 |
|
-0.02 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
3.48M |
|
-- |
|
-- |
|
-- |
|
0.69M |
|
2.79M |
|
2.79M |
|
2.79M |
|
159.37M |
|
| Cash Flow Statement Financials | |
-2.09M |
|
-0.42M |
|
0.55M |
|
3.97M |
|
2.01M |
|
-1.97M |
|
0.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-72.31% |
|
-72.31% |
|
-57.99% |
|
-72.31% |
|
0.02 |
|
-0.01 |
|
-0.01 |
|